Labeler
Genzyme Corporation NDC Codes
Genzyme Corporation lists 24 finished drug products in the FDA NDC Directory under NDC labeler code 58468.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Renvela, Qfitlia, Xenpozyme, Aubagio, Caprelsa, Fabrazyme, Wayrilz, Nexviazyme, Cablivi, Lemtrada, Cerdelga, Lumizyme, Campath, Aldurazyme, Thymoglobulin
- Active ingredients
- Sevelamer carbonate, Fitusiran, Olipudase alfa, Alemtuzumab, Teriflunomide, Vandetanib, Agalsidase beta, Rilzabrutinib, Avalglucosidase alfa, Eliglustat, Alglucosidase alfa, Laronidase
- NDC labeler codes
- 58468
- Strengths
- Sevelamer carbonate 800 mg/1; Agalsidase beta 5 mg/mL; Rilzabrutinib 400 mg/1; Fitusiran 20 mg/.2mL; Fitusiran 50 mg/.5mL; Olipudase alfa 20 mg/5.1mL; Olipudase alfa 4 mg/1.1mL; Avalglucosidase alfa 100 mg/10mL; Alemtuzumab 12 mg/1.2mL; Eliglustat 84 mg/1; Teriflunomide 14 mg/1; Teriflunomide 7 mg/1; Vandetanib 300 mg/1; Vandetanib 100 mg/1; Alglucosidase alfa 5 mg/mL; Alemtuzumab 30 mg/mL; Sevelamer carbonate 2400 mg/1; Laronidase 2.9 mg/5mL; Lapine t-lymphocyte immune globulin 5 mg/mL; Thyrotropin alfa .9 mg/mL
- Dosage forms
- Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Injection, Solution, Injection, Solution, Concentrate, Powder, For suspension, Kit, Capsule, Injection, Powder, For solution, Injection
- Routes
- Intravenous, Oral, Subcutaneous, Intramuscular
- Drug classes (FDA established)
- Phosphate Binder, Antithrombin-directed RNA Interaction, Small Interfering RNA, Hydrolytic Lysosomal Glycogen-specific Enzyme, CD52-directed Cytolytic Antibody, Pyrimidine Synthesis Inhibitor, Kinase Inhibitor, Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme, Glucosylceramide Synthase Inhibitor, Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme, Immunoglobulin G, Thyroid Stimulating Hormone, Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 31
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Wayrilzrilzabrutinib | Rilzabrutinib 400 mg/1 | Tablet, Film coatedOral | 58468-0251 | 58468-0251-0558468-0251-06 | — |
| Qfitliafitusiran | Fitusiran 20 mg/.2mL | Injection, SolutionSubcutaneous | 58468-0347 | 58468-0347-01 | — |
| Qfitliafitusiran | Fitusiran 50 mg/.5mL | Injection, SolutionSubcutaneous | 58468-0348 | 58468-0348-01 | — |
| Xenpozymeolipudase alfa-rpcp | Olipudase alfa 20 mg/5.1mL | Injection, Powder, Lyophilized, For solutionIntravenous | 58468-0050 | 58468-0050-01 | — |
| Xenpozymeolipudase alfa-rpcp | Olipudase alfa 4 mg/1.1mL | Injection, Powder, Lyophilized, For solutionIntravenous | 58468-0051 | 58468-0051-01 | — |
| Nexviazymeavalglucosidase alfa-ngpt | Avalglucosidase alfa 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 58468-0426 | 58468-0426-01 | — |
| Cablivicaplacizumab | — | Kit | 58468-0225 | 58468-0225-01 | — |
| Lemtradaalemtuzumab | Alemtuzumab 12 mg/1.2mL | Injection, Solution, ConcentrateIntravenous | 58468-0200 | 58468-0200-01 | — |
| Cerdelgaeliglustat | Eliglustat 84 mg/1 | CapsuleOral | 58468-0220 | 58468-0220-0158468-0220-02 | — |
| Aubagioteriflunomide | Teriflunomide 14 mg/1 | Tablet, Film coatedOral | 58468-0210 | 58468-0210-0158468-0210-0358468-0210-04 | — |
| Aubagioteriflunomide | Teriflunomide 7 mg/1 | Tablet, Film coatedOral | 58468-0211 | 58468-0211-0258468-0211-0358468-0211-04 | — |
| Caprelsavandetanib | Vandetanib 300 mg/1 | Tablet, Film coatedOral | 58468-7840 | 58468-7840-03 | — |
| Caprelsavandetanib | Vandetanib 100 mg/1 | Tablet, Film coatedOral | 58468-7820 | 58468-7820-03 | — |
| Lumizymealglucosidase alfa | Alglucosidase alfa 5 mg/mL | Injection, Powder, For solutionIntravenous | 58468-0160 | 58468-0160-01 | — |
| Campathalemtuzumab | Alemtuzumab 30 mg/mL | InjectionIntravenous | 58468-0357 | 58468-0357-0158468-0357-03 | — |
| Renvelasevelamer carbonate | Sevelamer carbonate 2400 mg/1 | Powder, For suspensionOral | 58468-0131 | 58468-0131-02 | — |
| Renvelasevelamer carbonate | Sevelamer carbonate 800 mg/1 | Powder, For suspensionOral | 58468-0132 | 58468-0132-02 | — |
| Renvelasevelamer carbonate | Sevelamer carbonate 800 mg/1 | Tablet, Film coatedOral | 58468-0133 | 58468-0133-01 | — |
| Fabrazymeagalsidase beta | Agalsidase beta 5 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 58468-0040 | 58468-0040-01 | — |
| Fabrazymeagalsidase beta | Agalsidase beta 5 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 58468-0041 | 58468-0041-01 | — |
| Aldurazymelaronidase | Laronidase 2.9 mg/5mL | Injection, Solution, ConcentrateIntravenous | 58468-0070 | 58468-0070-01 | — |
| Thymoglobulinanti-thymocyte globulin (rabbit) | Lapine t-lymphocyte immune globulin 5 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 58468-0080 | 58468-0080-01 | — |
| Thyrogenthyrotropin alfa | Thyrotropin alfa .9 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | 58468-0030 | 58468-0030-02 | — |
| Cerezymeimiglucerase | Imiglucerase 40 U/mL | Injection, Powder, Lyophilized, For solutionIntravenous | 58468-4663 | 58468-4663-01 | — |
Genzyme Corporation: common questions
- What is Genzyme Corporation's NDC labeler code?
- 58468. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Genzyme Corporation?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.